A Rational Approach to Karyotyping Utilization for Multiple Myeloma

被引:0
|
作者
Nasser, Nawaal [1 ]
Fatima, Nazneen [1 ]
El-Najjar, Vicky [1 ]
Guarner, Jeannette [1 ]
Jaye, David [1 ]
Hill, Charles [1 ]
机构
[1] Emory Univ, Dept Pathol & Lab Med, Atlanta, GA 30322 USA
关键词
D O I
暂无
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
80
引用
收藏
页码:436 / 436
页数:1
相关论文
共 50 条
  • [1] An Approach to Optimize FISH Test Utilization for Multiple Myeloma
    El-Najjar, Vicky
    Nasser, Nawaal
    Fatima, Nazneen
    Guarner, Jeannette
    Jaye, David
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2013, 140 (03) : 432 - 433
  • [2] A rational approach for the discovery of inhibitors of NSD2 for the treatment of multiple myeloma
    Fromond, Claudia
    Espanel, Xavier
    Estevez, Severine
    Adarbes, Vanessa
    Bocart, Stephanie
    Loillier, Bruno
    Soude, Anne
    Urban, Nathalie
    Bell, Frederic
    Masson, Philippe
    Boubia, BenaIssa
    Broqua, Pierre
    Montalbetti, Christian
    CANCER RESEARCH, 2016, 76
  • [3] Identification of new nonrandom translocations in multiple myeloma with multicolor spectral karyotyping
    Sawyer, JR
    Lukacs, JL
    Munshi, N
    Desikan, KR
    Singhal, S
    Mehta, J
    Siegel, D
    Shaughnessy, J
    Barlogie, B
    BLOOD, 1998, 92 (11) : 4269 - 4278
  • [4] Karyotypic complexity of multiple myeloma defined by multicolor spectral karyotyping (SKY).
    Rao, PH
    Cigudosa, J
    Ning, Y
    Calasanz, MJ
    Tagawa, S
    Michaele, S
    Klein, B
    DallaFavera, R
    Ried, T
    Chaganti, RSK
    BLOOD, 1997, 90 (10) : 381 - 381
  • [5] Karyotyping and DNA ploidy analysis by flow cytometer in patients with multiple myeloma
    Cho, S.
    Yoon, S.
    Kim, H.
    Park, J.
    Kim, H.
    INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2008, 30 : 108 - 108
  • [6] Toward a rational combinaTORial therapy for multiple myeloma
    Jernberg-Wiklund, H
    Nilsson, K
    BLOOD, 2004, 104 (13) : 3845 - 3846
  • [7] Multicolor spectral karyotyping identifies new recurring breakpoints and translocations in multiple myeloma
    Rao, PH
    Cigudosa, JC
    Ning, Y
    Calasanz, MJ
    Iida, S
    Tagawa, S
    Michaeli, J
    Klein, B
    Dalla-Favera, R
    Jhanwar, SC
    Ried, T
    Chaganti, RSK
    BLOOD, 1998, 92 (05) : 1743 - 1748
  • [8] Role of Conventional Karyotyping in Multiple Myeloma in the Era of Modern Treatment and FISH Analysis
    Soekojo, Cinnie Yentia
    Wang, Guo-miao
    Chen, Yunxin
    Casan, Joshua
    Wolyncewicz, Grace
    Lin, Adeline
    Poon, Li Mei
    de Mel, Sanjay
    Koh, Liang Piu
    Tan, Lip Kun
    Ooi, Melissa G.
    Nagarajan, Chandramouli
    Liu, Yang
    Lai, Yue-yun
    Hu, Xiao-Jun
    Spencer, Andrew
    Gopalakrishnan, Sathish Kumar
    Lu, Jin
    Chng, Wee Joo
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 (08): : E470 - E477
  • [9] Conventional Karyotyping and Fluorescence In Situ Hybridization for Detection of Chromosomal Abnormalities in Multiple Myeloma
    Crabtree, Matthew
    Cai, Jennifer
    Qing, Xin
    JOURNAL OF HEMATOLOGY, 2022, 11 (03) : 87 - 91
  • [10] Disparities in Healthcare Resource Utilization for Multiple Myeloma
    Fiala, Mark A.
    Wildes, Tanya M.
    Schroeder, Mark A.
    Ghobadi, Armin
    Stockerl-Goldstein, Keith E.
    Vij, Ravi
    BLOOD, 2018, 132